Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
22.11
+0.85 (4.00%)
At close: May 28, 2026, 4:00 PM EDT
22.49
+0.38 (1.72%)
After-hours: May 28, 2026, 5:39 PM EDT
Castle Biosciences Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Castle Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $45.88. The average 1-year stock price forecast is 107.51% higher than the current stock price, while the lowest is $40 (+80.91%) and the highest is $52 (+135.19%).
Price Target: $45.88 (+107.51%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Castle Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Reiterates $50 → $40 | Buy | Reiterates | $50 → $40 | +80.91% | May 13, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $44 → $43 | Buy | Maintains | $44 → $43 | +94.48% | May 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $40 | Buy | Maintains | $40 | +80.91% | May 7, 2026 |
| Lake Street | Lake Street | Buy Maintains $52 | Buy | Maintains | $52 | +135.19% | May 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $47 | Buy | Maintains | $47 | +112.57% | May 7, 2026 |
Financial Forecast
Revenue This Year
359.45M
from 344.23M
Increased by 4.42%
Revenue Next Year
400.76M
from 359.45M
Increased by 11.49%
EPS This Year
-1.45
from -0.83
EPS Next Year
-0.81
from -1.45
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 372.5M | 425.8M | ||||||
| Avg | 359.5M | 400.8M | ||||||
| Low | 343.2M | 376.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 8.2% | 18.5% | ||||||
| Avg | 4.4% | 11.5% | ||||||
| Low | -0.3% | 4.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -1.09 | -0.39 | ||||
| Avg | -1.45 | -0.81 | ||||
| Low | -1.71 | -1.05 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.